TEVA Cost of Revenue
Teva Pharmaceutical Industries Limited American Depositary Shares · Cost of Revenue
TEVA Cost of Revenue
Latest reported$8.23Bperiod ending
TEVA Cost of Revenue ($58.80M → $8.23B)
Annual cost of revenue
High-resolution chart · PNG
TEVA cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 8,320,000,000 | |
| 8,481,000,000 | |
| 8,200,000,000 | |
| 7,952,000,000 | |
| 8,284,000,000 | |
| 8,933,000,000 | |
| 9,351,000,000 | |
| 10,558,000,000 | |
| 11,560,000,000 | |
| 10,044,000,000 | |
| 8,296,000,000 | |
| 9,216,000,000 | |
| 9,607,000,000 | |
| 9,665,000,000 | |
| 8,797,000,000 | |
| 7,056,000,000 | |
| 6,532,000,000 | |
| 5,117,000,000 | |
| 4,531,000,000 | |
| 4,149,000,000 | |
| 2,769,800,000 | |
| 2,559,600,000 | |
| 1,757,500,000 | |
| 1,423,200,000 | |
| 1,230,077,000 | |
| 962,990,000 | |
| 699,203,000 | |
| 636,100,000 | |
| 628,900,000 | |
| 550,400,000 | |
| 364,100,000 | |
| 305,700,000 | |
| 268,500,000 | |
| 229,800,000 | |
| 194,100,000 | |
| 191,300,000 | |
| 180,700,000 | |
| 129,500,000 | |
| 84,900,000 | |
| 58,800,000 |